Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Pacira Pharmaceuticals
PCRX

Buy Pacira Pharmaceuticals (PCRX) Stock

PCRX
See PCRX stock price and Buy/Sell Pacira Pharmaceuticals with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
PCRX

Pacira Pharmaceuticals (PCRX)

About Pacira Pharmaceuticals (PCRX)

Pacira Biosciences, Inc. is a holding company, which provide non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam.The company was founded in December 2006 and is headquartered in Tampa, FL.
Market Cap
$2.8B
1 Year High
$82.16
Volume
59.97k
1 Year Low
$45.05
Price to Earnings Ratio
73.36
Open
$61.78
Dividend Rate
High
$64.03
Dividend Yield
Low
$61.78

Community

People who own or watch PCRX stock

Pacira Pharmaceuticals Stock News

Pacira Pharmaceuticals stock rating

What analysts recommend for PCRX stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1.5

Pacira Pharmaceuticals price target

What analysts think PCRX will be worth
Low $45.05
High $83.67
Current $63.91
Target $83.67

Events

List of events that could affect PCRX stock.
04May

Earnings data Q1 2022

02Aug

Earnings data Q2 2022

Pacira Pharmaceuticals earnings

The value each share was expected to gain vs. the value that each share actually gained
0.97
0.61
0.25
-0.12
Q3 2021
Q4 2021
Q1 2022
Q2 2022

Expected EPS
Q2 2022
$0.86
Actual EPS
Q2 2022

Buy Pacira Pharmaceuticals (PCRX) Stock

PCRX
See PCRX stock price and Buy/Sell Pacira Pharmaceuticals with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch PCRX stock
  • adroberts56 avatar
  • CubbageAdam avatar
  • Panerai1Eleven avatar
  • hectorsd avatar
  • MrJed avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.